急性冠動脈症候群とカートハーブアンフェタミン使用:観察報告
Waleed M Ali1, K F Al Habib, Ahmed Al-Motarreb
1Department of Cardiology, Hamad Medical Corp, Qatar.
Circulation
|December 14, 2011
まとめ
カットを噛むことは,急性冠動脈症候群の患者の死亡リスクや脳卒中のリスクを含む,より悪い結果と関連しています. カットに関する教育
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
- 公衆衛生は公衆衛生である.
背景:
- カット (Catha edulis) は,アンフェタミンのような効果を持つ刺激剤植物です.
- カットの使用は,アフリカの角とアラビア半島で一般的です.
- Khatは冠動脈のを誘発すると疑われています.
研究 の 目的:
- カット.を噛む急性冠動脈症候群 (ACS) 患者の臨床的特徴とアウトカムを評価する.
- カットを噛むことが心血管疾患の有害事象の独立リスク要因であるかどうかを判断する.
主な方法:
- 第2次湾岸急性冠状動脈事件レジストリ (Gulf RACE-2) のデータを分析した.
- 7399人のACS患者の中で,カットを噛む者と噛まない人の臨床的特徴とアウトカムの比較.
- ベースラインの患者変動に対する統計的調整.
主要な成果:
- ACS患者の19%はカトを噛む患者でした.
- カトを噛む人は,年長で,より男性的で,心拍数やキリップクラスの高さを示していた.
- カトを噛む人は,死亡,再発性イシュケミア,心臓発作性ショック,心室不律症,脳卒中のリスクが増加しました.
- カトを噛むことは,死亡,再発性不血症,心不全,脳卒中の独立リスク因子でした.
結論:
- カトを噛むことは,ACS患者における病院での結果の悪化と関連しています.
- カットを噛む人の悪影響は,イベントの1年後に続く.
- カットの心血管疾患のリスクに対する意識の向上は極めて重要です.
さらに関連する動画
関連する概念動画
Adrenergic Agonists: Indirect-Acting Agents
2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
Adrenergic Agonists: Mixed-Action Agents
1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.5K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.5K
Stimulants
1.4K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.4K
Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495


